Solicitation of Nominations for Appointment to the Communications and Public Engagement Workgroup (CPEW) of the Advisory Committee to the Director (ACD), CDC, 15578-15579 [2024-04430]

Download as PDF 15578 Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices comments may be made available to the Committee for their consideration and public distribution. Written comments should be submitted by email to CLIAC@cdc.gov or to the contact person above. All written comments will be included in the meeting minutes posted on the CLIAC website. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–04432 Filed 3–1–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Award of a Sole Source Cooperative Agreement To Fund Uganda National Health Laboratories and Diagnostic Services (NHLDS) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $10,000,000, for Year 1 funding to NHLDS. The award will strengthen laboratory systems in Uganda by contributing to the attainment of HIV epidemic control and establishing sustainable and integrated systems for quality assured disease diagnostics, monitoring, and surveillance. Funding amounts for years 2–5 will be set at continuation. DATES: The period for this award will be September 30, 2024, through September 29, 2029. FOR FURTHER INFORMATION CONTACT: Christina Mwangi, Center for Global Health, Centers for Disease Control and Prevention, US Embassy Kampala, US Centers for Disease Control and Prevention, 1577 Ggaba Road, Telephone: 256772139023, Email: mwn0@cdc.gov. khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:32 Mar 01, 2024 Jkt 262001 The sole source award will strengthen Uganda’s access to quality laboratory services during the scale up of HIV prevention, care, and treatment by supporting implementation of the Uganda National Health Laboratory Services (UNHLS) Policy II (2016) and its Strategic Plan (2020–2025). NHLDS is in a unique position to conduct this work, as it is the primary stakeholder of laboratory-related policy development, strategic planning, and resources mobilization for the Ministry of Health (MOH). Additionally, NHLDS directly houses and manages the Central Public Health Reference Laboratory (CPHL) which is the national reference laboratory for HIV early infant diagnosis and viral load, national microbiology reference laboratory, national Tuberculosis (TB) reference laboratory, the national laboratory biorepository and national equipment calibration center. Furthermore, the NHLDS is the primary coordinator of the integrated national laboratory specimen transportation network that handles both HIV, TB and outbreak specimen referral across the country. SUPPLEMENTARY INFORMATION: Summary of the Award Recipient: Uganda National Health Laboratories and Diagnostic Services (NHLDS). Purpose of the Award: The purpose of this award is to strengthen laboratory systems in Uganda by contributing to the attainment of HIV epidemic control and establishing sustainable and integrated systems for quality assured disease diagnostics, monitoring, and surveillance. Amount of Award: For NHLDS, the approximate year 1 funding amount will be $10,000,000 in Federal Fiscal Year (FYY) 2024 funds, subject to the availability of funds. Funding amounts for years 2–5 will be set at continuation. Authority: This program is authorized under Public Law 108–25 (the United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act of 2003) [22 U.S.C. 7601, et seq.] and Public Law 110–293 (the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008), and Public Law 113–56 (PEPFAR Stewardship and Oversight Act of 2013). Period of Performance: The period for this award will be September 30, 2024, through September 29, 2029. Dated: February 26, 2024. Jamie Legier, Acting Director, Office of Grants Services, Centers for Disease Control and Prevention. [FR Doc. 2024–04399 Filed 3–1–24; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Solicitation of Nominations for Appointment to the Communications and Public Engagement Workgroup (CPEW) of the Advisory Committee to the Director (ACD), CDC ACTION: Notice. The Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), is seeking nominations for membership to the Communications and Public Engagement Workgroup (CPEW) of the Advisory Committee to the Director, CDC. The CPEW workgroup consists of approximately 15 members who are experts in the fields associated with communications, including public relations, health communication, risk communication, communication research, and marketing; community and partner engagement; public health science and practice, including implementation; and behavioral science/behavior change campaigns. SUMMARY: Nominations for membership on the CPEW workgroup must be received no later than March 28, 2024. Late nominations will not be considered for membership. ADDRESSES: All nominations (cover letters and curriculum vitae) should be emailed to ACDirector@cdc.gov with the subject line: ‘‘Nomination for CDC ACD Communications and Public Engagement Workgroup.’’ FOR FURTHER INFORMATION CONTACT: Kate Galatas, MPH, Senior Communications Specialist, Office of Communications, Centers for Disease Control and Prevention, 1600 Clifton Road (MS H21–11), Atlanta, GA 30329–4027, Telephone: (404) 639–2064; Email: ACDirector@cdc.gov. SUPPLEMENTARY INFORMATION: Background: The purpose of the ACD, CDC Advisory Committee to the Director shall (1) make recommendations to the Director regarding ways to prioritize the activities of the agency in alignment with the CDC Strategic Plan required under section 305(c); H.R. 2617–1252; (2) advise on ways to achieve or improve performance metrics in relation to the CDC Strategic Plan, and other relevant metrics, as appropriate; (3) provide advice and recommendations on the development of the Strategic Plan, and any subsequent updates, as DATES: E:\FR\FM\04MRN1.SGM 04MRN1 khammond on DSKJM1Z7X2PROD with NOTICES Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices appropriate; (4) advise on grants, cooperative agreements, contracts, or other transactions, as applicable; (5) provide other advice to the Director, as requested, to fulfill duties under sections 301 and 311; and (6) appoint subcommittees. The ACD, CDC consists of up to 15 non-federal members, including the Chair, knowledgeable in areas pertinent to the CDC mission, such as health policy, public health, global health, preparedness, preventive medicine, the faith-based and community-based sector, and allied fields. Purpose: The establishment and formation of the ACD, Communications and Public Engagement Workgroup (CPEW) is to provide input to the Committee on agency-wide activities related to how CDC communicates directly and more effectively with the public, with a focus on reaching local communities with messages. Effective communication with the public includes, but is not limited to: (1) building relationships and mechanisms to communicate via trusted messengers, including but not limited to, clinicians, faith and community leaders, and health department officials at the national, state and local levels; (2) improving risk communication practices; (3) delivering more action-oriented and focused communications to help people protect their health (e.g., effective messages and storytelling); (4) tailoring our messages and communications methods, as appropriate, to audiences, particularly for historically marginalized communities; and (5) increasing transparency by stepping up the pace, content and reach of our communications (e.g., considering impact of different communications channels, such as blogs, TV interviews, emerging platforms). The CPEW membership consists of approximately 15 members. It is cochaired by two current ACD, CDC Special Government Employees. The CPEW co-chairs will present their findings, observations, and work products at one or more ACD, CDC meetings for discussion, deliberation, and decisions (final recommendations to CDC). Nomination Criteria: CPEW members will serve terms ranging from six months to one year and be required to attend CPEW meetings approximately once per month (virtually or in person), and contribute time in between meetings for research, consultation, discussion, and writing assignments. Nominations are being sought for individuals who have the expertise and qualifications necessary to contribute to the accomplishments of the VerDate Sep<11>2014 17:45 Mar 01, 2024 Jkt 262001 committee’s/workgroup’s objectives. Nominees will be selected based on expertise in the fields of communications, including public relations, health communication, risk communication, communication research, and marketing; community and partner engagement; public health science and practice, including implementation; and behavioral science/behavior change campaigns. Federal employees will not be considered for membership. Selection of members is based on candidates’ qualifications to contribute to the accomplishment of the CPEW’s objectives. HHS policy stipulates that membership be balanced in terms of points of view represented and the workgroup’s function. Appointments shall be made without discrimination based on age, race, ethnicity, gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens and cannot be fulltime employees of the U.S. Government. Current participation on federal workgroups or prior experience serving on a federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive individual service on advisory committees and multiple committee memberships. Interested candidates should submit the following items: • A one-half to one-page cover letter that includes your understanding of, and commitment to, the time and work necessary; one to two sentences on your background and experience; and one to two sentences on the skills/perspective you would bring to the CPEW. • At least one letter of recommendation from person(s) not employed by the U.S. Department of Health and Human Services. (Candidates may submit letter(s) from current HHS employees if they wish, but at least one letter must be submitted by a person not employed by an HHS agency (e.g., CDC, NIH, FDA, etc.). • Current curriculum vitae which highlights the experience and work history being sought relevant to the criteria set forth above, including complete contact information (telephone numbers, mailing address, email address). Nominations may be submitted by the candidate him or herself, or by the person/organization recommending the candidate. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 15579 Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–04430 Filed 3–1–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Meeting of the Mine Safety and Health Research Advisory Committee Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Mine Safety and Health Research Advisory Committee (MSHRAC). This is a hybrid meeting, accessible both in person and virtually. It is open to the public and limited only by the space available and the number of web conference lines available. Time will be available for public comment. DATES: The meeting will be held on April 17, 2024, from 8:30 a.m. to 4:10 p.m., EDT. ADDRESSES: Mine Safety and Heath Administration’s Approval and Certification Center, 765 Technology Drive, Triadelphia, West Virginia 26059. The conference room accommodates approximately 49 people. Please note that the meeting location is a Federal facility and in-person access is limited to U.S. citizens unless prior authorizations, taking up to 30 to 60 days, have been made. If you wish to attend the meeting either in person or virtually, please contact Ms. Berni Metzger by email at Metzger@cdc.gov or by phone at (412) 386–4541 at least 5 business days in advance of the meeting. If you are attending virtually, she will provide you with the Zoom web conference access information (500 web conference lines are available). FOR FURTHER INFORMATION CONTACT: Steven Mischler, Ph.D., Designated Federal Officer, Mine Safety and Health SUMMARY: E:\FR\FM\04MRN1.SGM 04MRN1

Agencies

[Federal Register Volume 89, Number 43 (Monday, March 4, 2024)]
[Notices]
[Pages 15578-15579]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-04430]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Solicitation of Nominations for Appointment to the Communications 
and Public Engagement Workgroup (CPEW) of the Advisory Committee to the 
Director (ACD), CDC

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), within 
the Department of Health and Human Services (HHS), is seeking 
nominations for membership to the Communications and Public Engagement 
Workgroup (CPEW) of the Advisory Committee to the Director, CDC. The 
CPEW workgroup consists of approximately 15 members who are experts in 
the fields associated with communications, including public relations, 
health communication, risk communication, communication research, and 
marketing; community and partner engagement; public health science and 
practice, including implementation; and behavioral science/behavior 
change campaigns.

DATES: Nominations for membership on the CPEW workgroup must be 
received no later than March 28, 2024. Late nominations will not be 
considered for membership.

ADDRESSES: All nominations (cover letters and curriculum vitae) should 
be emailed to [email protected] with the subject line: ``Nomination 
for CDC ACD Communications and Public Engagement Workgroup.''

FOR FURTHER INFORMATION CONTACT: Kate Galatas, MPH, Senior 
Communications Specialist, Office of Communications, Centers for 
Disease Control and Prevention, 1600 Clifton Road (MS H21-11), Atlanta, 
GA 30329-4027, Telephone: (404) 639-2064; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Background: The purpose of the ACD, CDC Advisory Committee to the 
Director shall (1) make recommendations to the Director regarding ways 
to prioritize the activities of the agency in alignment with the CDC 
Strategic Plan required under section 305(c); H.R. 2617-1252; (2) 
advise on ways to achieve or improve performance metrics in relation to 
the CDC Strategic Plan, and other relevant metrics, as appropriate; (3) 
provide advice and recommendations on the development of the Strategic 
Plan, and any subsequent updates, as

[[Page 15579]]

appropriate; (4) advise on grants, cooperative agreements, contracts, 
or other transactions, as applicable; (5) provide other advice to the 
Director, as requested, to fulfill duties under sections 301 and 311; 
and (6) appoint subcommittees. The ACD, CDC consists of up to 15 non-
federal members, including the Chair, knowledgeable in areas pertinent 
to the CDC mission, such as health policy, public health, global 
health, preparedness, preventive medicine, the faith-based and 
community-based sector, and allied fields.
    Purpose: The establishment and formation of the ACD, Communications 
and Public Engagement Workgroup (CPEW) is to provide input to the 
Committee on agency-wide activities related to how CDC communicates 
directly and more effectively with the public, with a focus on reaching 
local communities with messages. Effective communication with the 
public includes, but is not limited to: (1) building relationships and 
mechanisms to communicate via trusted messengers, including but not 
limited to, clinicians, faith and community leaders, and health 
department officials at the national, state and local levels; (2) 
improving risk communication practices; (3) delivering more action-
oriented and focused communications to help people protect their health 
(e.g., effective messages and storytelling); (4) tailoring our messages 
and communications methods, as appropriate, to audiences, particularly 
for historically marginalized communities; and (5) increasing 
transparency by stepping up the pace, content and reach of our 
communications (e.g., considering impact of different communications 
channels, such as blogs, TV interviews, emerging platforms).
    The CPEW membership consists of approximately 15 members. It is co-
chaired by two current ACD, CDC Special Government Employees. The CPEW 
co-chairs will present their findings, observations, and work products 
at one or more ACD, CDC meetings for discussion, deliberation, and 
decisions (final recommendations to CDC).
    Nomination Criteria: CPEW members will serve terms ranging from six 
months to one year and be required to attend CPEW meetings 
approximately once per month (virtually or in person), and contribute 
time in between meetings for research, consultation, discussion, and 
writing assignments.
    Nominations are being sought for individuals who have the expertise 
and qualifications necessary to contribute to the accomplishments of 
the committee's/workgroup's objectives. Nominees will be selected based 
on expertise in the fields of communications, including public 
relations, health communication, risk communication, communication 
research, and marketing; community and partner engagement; public 
health science and practice, including implementation; and behavioral 
science/behavior change campaigns. Federal employees will not be 
considered for membership. Selection of members is based on candidates' 
qualifications to contribute to the accomplishment of the CPEW's 
objectives.
    HHS policy stipulates that membership be balanced in terms of 
points of view represented and the workgroup's function. Appointments 
shall be made without discrimination based on age, race, ethnicity, 
gender, sexual orientation, gender identity, HIV status, disability, 
and cultural, religious, or socioeconomic status. Nominees must be U.S. 
citizens and cannot be full-time employees of the U.S. Government. 
Current participation on federal workgroups or prior experience serving 
on a federal advisory committee does not disqualify a candidate; 
however, HHS policy is to avoid excessive individual service on 
advisory committees and multiple committee memberships. Interested 
candidates should submit the following items:
     A one-half to one-page cover letter that includes your 
understanding of, and commitment to, the time and work necessary; one 
to two sentences on your background and experience; and one to two 
sentences on the skills/perspective you would bring to the CPEW.
     At least one letter of recommendation from person(s) not 
employed by the U.S. Department of Health and Human Services. 
(Candidates may submit letter(s) from current HHS employees if they 
wish, but at least one letter must be submitted by a person not 
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
     Current curriculum vitae which highlights the experience 
and work history being sought relevant to the criteria set forth above, 
including complete contact information (telephone numbers, mailing 
address, email address).
    Nominations may be submitted by the candidate him or herself, or by 
the person/organization recommending the candidate.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-04430 Filed 3-1-24; 8:45 am]
BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.